Quest Diagnostics, Inc.

NYSE:DGX   10:23:00 AM EDT
125.91
+2.08 (+1.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)17.05B
Current PE14.76
Forward PE 12.17
2yr Forward PE 11.88
See more stats
Estimates Current Quarter
Revenue$2.77 Billion
Adjusted EPS$3.71
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

QUEST DIAGNOSTICS INC Stock, NYSE:DGX

500 PLAZA DRIVE, SECAUCUS, NJ 07094
United States of America
Phone: 9735202700
Number of Employees: 46000

Description

Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. The company's Diagnostic Information Services business segment develops and delivers diagnostic testing information and services, such as routine testing, gene-based and esoteric testing, and drugs-of-abuse testing, as well as anatomic pathology services, and related services and insights. This segment offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum, and Care360 brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, and phlebotomists in physician offices. Its Diagnostic Solutions segment offers risk assessment services for the life insurance industry; and health information technology solutions for healthcare organizations and clinicians. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Madison, New Jersey.